Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
4.140
+0.050 (1.22%)
At close: May 27, 2026, 4:00 PM EDT
4.100
-0.040 (-0.97%)
After-hours: May 27, 2026, 4:49 PM EDT
Opus Genetics Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Opus Genetics stock has a consensus rating of "Strong Buy" and an average price target of $10.13. The average 1-year stock price forecast is 144.69% higher than the current stock price, while the lowest is $8.00 (+93.24%) and the highest is $15 (+262.32%).
Price Target: $10.13 (+144.69%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Opus Genetics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 10 | 11 | 13 | 13 | 14 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 12 | 14 | 15 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $10 | Buy | Initiates | $10 | +141.55% | May 21, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $10 | Buy | Maintains | $10 | +141.55% | May 16, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $15 | Buy | Maintains | $15 | +262.32% | May 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $8 | Buy | Reiterates | $8 | +93.24% | May 13, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $12 → $11 | Buy | Maintains | $12 → $11 | +165.70% | May 13, 2026 |
Financial Forecast
Revenue This Year
14.09M
from 14.20M
Decreased by -0.75%
Revenue Next Year
16.12M
from 14.09M
Increased by 14.42%
EPS This Year
-0.77
from -0.80
EPS Next Year
-0.64
from -0.77
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 27.6M | 34.9M | ||||||
| Avg | 14.1M | 16.1M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 94.5% | 147.8% | ||||||
| Avg | -0.8% | 14.4% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.37 | -0.29 | ||||||
| Avg | -0.77 | -0.64 | ||||||
| Low | -1.24 | -1.06 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.